| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/267:00 AM | -$1.02 | -$0.81GAAP | +20.6% | -138% | $4.9M | $0.0M | ⚠ Check | -64% | |
| Q2 '26 | 8/6/267:00 AM | -$1.02 | -$1.05GAAP | -2.9% | -5% | $0.0M | $0.2M | ⚠ Check | +211% | |
| Q1 '26 | 5/5/267:00 AM | -$1.07 | -$0.90GAAP | +15.9% | -3% | $0.0M | $0.1M | ⚠ Check | +96% | |
| Q4 '25 | 2/26/267:01 AM | -$0.96 | -$1.08GAAP | -12.5% | -33% | $16.8M | $0.1M | ⚠ Check | +83% | |
| Q3 '25 | 11/5/257:00 AM | -$0.89 | -$0.34GAAP | +61.8% | +61% | $25.7M | $0.1M | ⚠ Check | -18% | |
| Q2 '25 | 8/6/256:30 AM | -$0.98 | -$1.00GAAP | -2.0% | +2% | $0.1M | $0.1M | -15.0% | +4% | |
| Q1 '25 | 5/6/257:00 AM | -$0.96 | -$0.87GAAP | +9.4% | -10% | $0.0M | $0.1M | +63.3% | 0% |
⚠ Potential error in calculation, check manually. The two revenue figures may be in different units or currencies.
GAAP = diluted EPS as filed with the SEC.